<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Chem</journal-id><journal-id journal-id-type="iso-abbrev">BMC Chem</journal-id><journal-title-group><journal-title>BMC Chemistry</journal-title></journal-title-group><issn pub-type="epub">2661-801X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7934435</article-id><article-id pub-id-type="publisher-id">742</article-id><article-id pub-id-type="doi">10.1186/s13065-021-00742-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Experimental and computational studies of an antiplasmodial derivative of allantoin; antimycobacterial essential oil from <italic>Cordia batesii</italic> WERNHAM (Boraginaceae)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tiam</surname><given-names>Eric Robert</given-names></name><address><email>tim007820030@yahoo.fr</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bikobo</surname><given-names>Dominique Serge Ngono</given-names></name><address><email>ngono_serge@yahoo.fr</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ndassa</surname><given-names>Ibrahim Mbouombouo</given-names></name><address><email>indassa@yahoo.fr</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Nyemeck II</surname><given-names>Norbert Mbabi</given-names></name><address><email>mbabi2002@yahoo.fr</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>A Zintchem</surname><given-names>Auguste Abouem</given-names></name><address><email>augabouem@yahoo.fr</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ayong</surname><given-names>Lawrence</given-names></name><address><email>ayong@pasteur-yaounde.org</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Dibou&#x000e9;</surname><given-names>Patrick Herv&#x000e9; Betote</given-names></name><address><email>pbetotedidoue@yahoo.fr</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ndjakou</surname><given-names>Bruno Lenta</given-names></name><address><email>lentabruno@yahoo.fr</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Mbing</surname><given-names>Jos&#x000e9;phine Ngo</given-names></name><address><email>jpmbing15@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Pegnyemb</surname><given-names>Dieudonn&#x000e9; Emmanuel</given-names></name><address><email>pegnyemb@yahoo.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.412661.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2173 8504</institution-id><institution>Department of Organic Chemistry, Faculty of Science, </institution><institution>University of Yaound&#x000e9; I, </institution></institution-wrap>P.O Box 812, Yaounde, Cameroon </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412661.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2173 8504</institution-id><institution>Department of Inorganic Chemistry, Faculty of Science, </institution><institution>University of Yaound&#x000e9; I, </institution></institution-wrap>P.O Box 812, Yaounde, Cameroon </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.412661.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2173 8504</institution-id><institution>Department of Chemistry, Higher Training College, </institution><institution>University of Yaound&#x000e9; I, </institution></institution-wrap>P.O Box 47, Yaounde, Cameroon </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.418179.2</institution-id><institution>Centre Pasteur du Cameroun, </institution></institution-wrap>Yaounde, Cameroon </aff><aff id="Aff5"><label>5</label>Centre for Research on Medicinal Plants and Traditional Medicine, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon </aff></contrib-group><pub-date pub-type="epub"><day>5</day><month>3</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>5</day><month>3</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2021</year></pub-date><volume>15</volume><issue>1</issue><elocation-id>15</elocation-id><history><date date-type="received"><day>23</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>2</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Chemical and pharmacological investigations were performed on the stems of <italic>Cordia batesii</italic> (Boraginaeae); chemical studies included quantum calculations applied on a newly described compound.</p></sec><sec><title>Results</title><p id="Par2">A new derivative of allantoin (<bold>1</bold>) named batesiin (<bold>2</bold>) was characterized. Thirteen other known compounds involving allantoin (<bold>1</bold>) were either isolated or identified. GC&#x02013;MS enabled the identification of six compounds from a fraction containing essential oil. MeOH extract and some isolated compounds were tested in vitro against <italic>Pf</italic>7G8 CQS and <italic>Pf</italic> Dd2 CQR strains of <italic>Plasmodium falciparum</italic>; extract disclosed a moderate antiplasmodial activity (IC<sub>50</sub>&#x02009;=&#x02009;50&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>). Meantime, the CH<sub>2</sub>Cl<sub>2</sub> extract and essential oil fraction were tested on a resistant mycobacterial strain of <italic>Mycobacterium tuberculosis</italic>; a potent antimycobacterial activity with a MIC&#x02009;=&#x02009;9.52&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> was deduced from essential oil. Density functional theory (DFT) calculations were carried on batesiin (<bold>2</bold>). Calculated chemical shifts at B3LYP/6-31G(d,p) and MPW1PW91/6-31G+(d,p) showed much better correlations with the experimental data. Time dependent DFT at B3LYP/6-31G+(d,p) displayed a major absorption band 3.01&#x000a0;nm higher than the experimental value.</p></sec><sec><title>Conclusion</title><p id="Par3"><italic>Cordia batesii</italic> can be considered as promising in search of compounds with antimalarial and antitubercular properties. DFT studies are very helpful when trying to learn more about the spectroscopic insights of a derivative of allantoin (<bold>1</bold>).</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic>Cordia batesii</italic></kwd><kwd>Allantoin</kwd><kwd>Batesiin</kwd><kwd>Spectroscopy</kwd><kwd>Essential oil</kwd><kwd>DFT</kwd><kwd>Molecular orbitals</kwd><kwd><italic>Plasmodium falciparum</italic></kwd><kwd><italic>Mycobacterium tuberculosis</italic></kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par4">One of the main goals of World Health Organization (WHO) is to end the epidemics of neglected tropical diseases, tuberculosis (TB) and malaria (which remains the major public health and mortality problem in the tropics) by 2030 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. In 2018, TB infected about 10.0 million people, mainly in WHO regions of South-East Asia (44%), Africa (24%) and the Western Pacific (18%); in parallel, about 213 million cases of malaria were found in the WHO African region. In the same year, half a million newly rifampicin-resistant TB cases were estimated. In general, 3.4% of new TB cases and 18% of formerly cured patients displayed either multidrug resistant TB or rifampicin-resistant TB (MDR/RR-TB) [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. Trying to overcome the high cost or the shortage of drugs for treatment of malaria remains a challenge for chemists, and some authors proposed the synthesis of compounds disclosing an imidazole unit with efficient activities against malaria [<xref ref-type="bibr" rid="CR6">6</xref>]. Recently, Al-Otaibi et al. [<xref ref-type="bibr" rid="CR7">7</xref>] reported quantum calculations achieved on such derivatives; in their work, the authors evaluated the structural and electronic traits of those derivatives. <sup>1</sup>H- and <sup>13</sup>C-NMR spectroscopy is a central tool in the structure elucidation of organic compounds. A review by Lodewyk et al. [<xref ref-type="bibr" rid="CR8">8</xref>] emphasized on computational predictions of NMR data on synthetic organic compounds and natural products. Natural products can be isolated from plants, which are considered to be an important source of major compounds in drug development because of their successful use in treating various human ailments since millenniums. In this context, searching for new natural products from medicinal plants could provide new ways for antimalarial and antitubercular drugs. Among these plants, some species of the genus <italic>Cordia</italic> (Boraginaceae) are reported to be useful in the treatment of tuberculosis, bronchitis and malaria [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par5">The genus <italic>Cordia</italic> (Boraginaceae) is composed of trees or shrubs and is widespread in Central and South America, India, Asia and Africa [<xref ref-type="bibr" rid="CR10">10</xref>]. Previous phytochemical investigations of plants from this genus reported the isolation and characterization of different classes of secondary metabolites including naphthoquinones, hydroquinones [<xref ref-type="bibr" rid="CR11">11</xref>] or polyphenols [<xref ref-type="bibr" rid="CR12">12</xref>]. Concurrently and based on some pharmacological surveys, essential oils from <italic>C</italic>. <italic>curassivica</italic> and <italic>C</italic>. <italic>gilletii</italic> appeared as active against some microbial strains [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Biological activities and in silico investigations of <italic>C</italic>. <italic>dichotoma</italic> were recently reported [<xref ref-type="bibr" rid="CR15">15</xref>]; the plant is also known to contain, apart from allantoin (<bold>1</bold>) [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] which has been the subject of many quantum calculations [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], fatty acids (FA) [<xref ref-type="bibr" rid="CR20">20</xref>]. FA have been recognized as energy sources for <italic>M</italic>. <italic>tuberculosis</italic> inside host tissues and are supposed to induce dormancy in <italic>Mycobacterium</italic> bacilli [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. A few <italic>Mycobacterium</italic> bacilli were inhibited by <italic>C</italic>. <italic>sebestena</italic> extracts as results of biological analyses [<xref ref-type="bibr" rid="CR23">23</xref>]. Sebestenoid D is a component of the latter species and was a matter of density functional theory (DFT) studies, with its optimized molecular geometry and HOMO&#x02013;LUMO plot as outcomes [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) were also calculated during a survey aiming to check the coherence between experimental and theoretical NMR and IR data; this investigation was done on a compound with an imidazole unit [<xref ref-type="bibr" rid="CR26">26</xref>] like allantoin (<bold>1</bold>). Other simulations completed on a particular range of complex natural products involved IR as well as electronic transitions for UV analyses through time dependent DFT (TD-DFT); findings were afterwards compared to experimental results [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par6">Despite the intensive work performed on some <italic>Cordia</italic> species, no or less investigation has been done on <italic>Cordia batesii</italic> species, maybe because of its limited geographic location. In our continuing search of secondary metabolites with powerful antiplasmodial and antitubercular activities, chemical investigations were carried on the stems of <italic>Cordia batesii</italic>, a forest shrub growing in the central and western regions of Cameroon. This paper describes the isolation of a new derivative of <bold>1</bold> named batesiin (<bold>2</bold>) along with other compounds. In vitro activities regarding extracts of stems and some isolated compounds against two CQR strains of <italic>Plasmodium falciparum</italic> were examined, when essential oil from the plant was tested against a resistant mycobacterial strain of <italic>Mycobacterium tuberculosis</italic>. The detailed characterization of <bold>2</bold> was investigated based on experimental NMR and UV&#x02013;visible spectroscopic analyses; DFT at B3LYP/6-31G(d,p) [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] and MPW1PW91/6-31G+(d,p) [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] and TD-DFT simulations at B3LYP/6-31G+(d,p) were then undertaken on the alleged structure. These quantum calculations were applied on <bold>2</bold> for two main reasons: the compound is described for the first time, its NMR data are closed to chemical shifts of <bold>1</bold> but the UV&#x02013;visible spectra of both seem different. DFT calculations at B3LYP/6-311G++(d,p) were also performed to check some electronic and thermodynamic properties of <bold>2</bold>.</p></sec><sec id="Sec2"><title>Results</title><sec id="Sec3"><title>Experimental results</title><p id="Par7">Compounds <bold>1</bold>, <bold>3</bold>&#x02013;<bold>14</bold> were identified based on comparison of their physical and spectral data with authentic samples or those already reported (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Their assignments were consistent with structures of: allantoin (<bold>1</bold>) [<xref ref-type="bibr" rid="CR32">32</xref>], pyrimidine 2,4-(1<italic>H</italic>,3<italic>H</italic>)-dione (<bold>3</bold>) [<xref ref-type="bibr" rid="CR33">33</xref>], cordialin A (<bold>4</bold>) and cordialin B (<bold>5</bold>) [<xref ref-type="bibr" rid="CR34">34</xref>], quercetin (<bold>6</bold>) [<xref ref-type="bibr" rid="CR35">35</xref>], myricetin (<bold>7</bold>) [<xref ref-type="bibr" rid="CR36">36</xref>], genistein 4&#x02032;-<italic>O</italic>-glucuronide (<bold>8</bold>) [<xref ref-type="bibr" rid="CR37">37</xref>], methyl palmitate (<bold>9</bold>) [<xref ref-type="bibr" rid="CR38">38</xref>], palmitic acid (<bold>10</bold>) [<xref ref-type="bibr" rid="CR39">39</xref>], methyl (9<italic>E</italic>,12<italic>E</italic>)-octadeca-9,12-dienoate (<bold>11</bold>) [<xref ref-type="bibr" rid="CR40">40</xref>], methyl oleate (<bold>12</bold>) [<xref ref-type="bibr" rid="CR41">41</xref>], methyl tridecanoate (<bold>13</bold>) [<xref ref-type="bibr" rid="CR42">42</xref>] and (<italic>Z</italic>)-octadec-11-enoic acid (<bold>14</bold>) [<xref ref-type="bibr" rid="CR43">43</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Structures of the isolated/identified compounds (<bold>1&#x02013;14</bold>) from the stems of <italic>C</italic>. <italic>batesii</italic></p></caption><graphic xlink:href="13065_2021_742_Fig1a_HTML" id="MO1"/><graphic xlink:href="13065_2021_742_Fig1b_HTML" id="d32e755"/></fig></p></sec><sec id="Sec4"><title>Characterization of compound 2</title><p id="Par8">Compound <bold>2</bold> was isolated as a white solid from CH<sub>2</sub>Cl<sub>2</sub>/MeOH mixture. Its molecular formula was deduced as C<sub>7</sub>H<sub>8</sub>N<sub>6</sub>O<sub>5</sub> from the ESI-MS signal at <italic>m/z</italic> 257.4 [M+H]<sup>+</sup> and from the HR-LC/MS signal at <italic>m/z</italic> 279.1603 [M+Na]<sup>+</sup>, in accordance with seven degrees of unsaturations. Additional data from the ESI-MS spectrum displayed other peaks at <italic>m/z</italic> 159.4 [M<sub>1</sub>+H]<sup>+</sup> and 181.6 [M<sub>1</sub>&#x02009;+&#x02009;Na]<sup>+</sup> which are characteristics of allantoin (<bold>1</bold>) [<xref ref-type="bibr" rid="CR44">44</xref>]. These preliminary data suggested a close relationship between allantoin (<bold>1</bold>) and compound <bold>2</bold>. The <sup>1</sup>H-NMR spectrum of <bold>2</bold> exhibited a very prominent peak at &#x003b4;<sub>H</sub> 5.30 (2H, d<italic>, </italic><sup><italic>3</italic></sup><italic>&#x000a0;J</italic>(H,H)&#x02009;=&#x02009;2.0&#x000a0;Hz, H&#x02013;C(5)) ppm. Moreover, we observed from the same spectrum some signals attributable to protons attached to heteroatoms (especially to nitrogen) with chemical shifts at &#x003b4;<sub>H</sub> 8.04 [2H, s, H&#x02013;N(1)], 10.51 [2H, s, H&#x02013;N(3)], 6.86 [2H, d, <sup><italic>3</italic></sup><italic>&#x000a0;J</italic>(H,H)&#x02009;=&#x02009;2.0&#x000a0;Hz, H&#x02013;N(6)] ppm (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p><sup>1</sup>H- and <sup>13</sup>C-NMR 1D and 2D spectroscopic data of <bold>1</bold> and <bold>2</bold> (500 and 125&#x000a0;MHz in DMSO-<italic>d</italic><sub>6</sub>) in ppm</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Position</th><th align="left" colspan="2">Allantoin (1) [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]</th><th align="left" colspan="2">Batesiin (2)</th></tr><tr><th align="left">&#x003b4;<sub>C</sub></th><th align="left">&#x003b4;<sub>H</sub></th><th align="left">&#x003b4;<sub>C</sub></th><th align="left">&#x003b4;<sub>H</sub> (m, <italic>J</italic>)</th></tr></thead><tbody><tr><td align="left">2</td><td align="left">156.7</td><td align="left">&#x02013;</td><td align="left">156.8</td><td align="left">&#x02013;</td></tr><tr><td align="left">4</td><td align="left">173.4</td><td align="left">&#x02013;</td><td align="left">173.6</td><td align="left">&#x02013;</td></tr><tr><td align="left">5</td><td align="left">62.3</td><td align="left">5.23</td><td align="left">62.4</td><td align="left">5.30 (d, 2.0&#x000a0;Hz, 2H)</td></tr><tr><td align="left">7</td><td align="left">157.4</td><td align="left">&#x02013;</td><td align="left">157.4</td><td align="left">&#x02013;</td></tr><tr><td align="left">H&#x02013;N(1)</td><td align="left">&#x02013;</td><td align="left">8.04</td><td align="left">&#x02013;</td><td align="left">8.04 (s, 2H)</td></tr><tr><td align="left">H&#x02013;N(3)</td><td align="left">&#x02013;</td><td align="left">10.62</td><td align="left">&#x02013;</td><td align="left">10.51 (s, 2H)</td></tr><tr><td align="left">H&#x02013;N(6)</td><td align="left">&#x02013;</td><td align="left">6.88</td><td align="left">&#x02013;</td><td align="left">6.88 (d, 2.0&#x000a0;Hz, 2H)</td></tr></tbody></table></table-wrap></p><p id="Par9">The <sup>13</sup>C-NMR spectrum of <bold>2</bold> showed four remarkable signals at 157.4 [C(2), 2C], 173.6 [C(4), 2C], 62.4 [C(5), 2C] and 156.8 [C(7), 1C] ppm; when considering that <bold>2</bold> contains seven carbon atoms, the number of aforementioned signals presume the occurrence of a symmetry. The DEPT 135 NMR spectrum of <bold>2</bold> revealed one signal at &#x003b4;<sub>C</sub> 62.4 [C(5)] ppm indicating one methine group. These observations were confirmed by its HSQC spectrum which indicates a correlation between the proton at &#x003b4;<sub>H</sub> 5.30&#x000a0;ppm [H&#x02013;C(5)] and the said carbon. Two remaining signals from the <sup>13</sup>C NMR spectrum are observable at &#x003b4;<sub>C</sub> 48.6 and 54.9&#x000a0;ppm and are suggestive of signals of MeOH and CH<sub>2</sub>Cl<sub>2</sub> respectively; this assertion is strengthened by correlations between signals at &#x003b4;<sub>C</sub> 48.6 and &#x003b4;<sub>H</sub> 3.17&#x000a0;ppm in one side, and signals at &#x003b4;<sub>C</sub> 54.9 and &#x003b4;<sub>H</sub> 5.74&#x000a0;ppm from the same HSQC spectrum [<xref ref-type="bibr" rid="CR45">45</xref>].</p><p id="Par10">The HMBC spectrum exhibited noticeable correlations between protons at &#x003b4;<sub>H</sub> 5.30&#x000a0;ppm [H&#x02013;C(5)] and the carbon atoms at &#x003b4;<sub>C</sub> 173.6&#x000a0;ppm [C(4)] and 156.8&#x000a0;ppm [C(7)], between protons at &#x003b4;<sub>H</sub> 6.88&#x000a0;ppm [H&#x02013;N(6)] and carbon atoms at &#x003b4;<sub>C</sub> 173.6 [C(4)], 62.4 [C(5)] and 156.8 [C(7)]. Other correlations were found between nitrogenous protons at &#x003b4;<sub>H</sub> 8.04 [H&#x02013;N(1)] ppm and carbon atoms at &#x003b4;<sub>C</sub> 157.3&#x000a0;ppm [C(2)], &#x003b4;<sub>C</sub> 173.6&#x000a0;ppm [C(4)] and 62.4&#x000a0;ppm [C(5)]. The UV spectrum of <bold>2</bold> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) exhibited one major maximum at &#x003bb;<sub>max</sub>&#x02009;=&#x02009;296&#x000a0;nm, different from values of <bold>1</bold> [<xref ref-type="bibr" rid="CR19">19</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>UV&#x02013;visible spectrum of batesiin (<bold>2</bold>)</p></caption><graphic xlink:href="13065_2021_742_Fig2_HTML" id="MO2"/></fig></p><p id="Par11">Lakshmanan et al. [<xref ref-type="bibr" rid="CR44">44</xref>] confirmed through an X-ray analysis that the occurring enantiomer of <bold>1</bold> is its (<italic>S</italic>) one. A thorough analysis of all the spectra and comparison with data from the literature revealed that compound <bold>2</bold> is described for the first time as a new derivative of allantoin (<bold>1</bold>); it was identified as (<italic>S</italic>,<italic>S</italic>)-1,3-bis(2,5-dioxoimidazolidin-4-yl)urea, trivially named batesiin (<bold>2</bold>). Table <xref rid="Tab1" ref-type="table">1</xref> shows some NMR data of allantoin (<bold>1</bold>) and batesiin (<bold>2</bold>); it strengthens the agreement of a close relationship between those two compounds in terms of NMR spectroscopic data.</p></sec><sec id="Sec5"><title>Biological properties</title><p id="Par12">The antimalarial efficiency of screening against <italic>P. falciparum</italic> Dd2 and 7G8 (CQR) strains of the MeOH extract of stems of <italic>C</italic>. <italic>batesii</italic> and compounds <bold>2</bold>, <bold>3</bold>, <bold>5</bold> and <bold>6</bold> was performed according to the Sybr Green I fluorescence-based assays [<xref ref-type="bibr" rid="CR46">46</xref>]. The results are presented in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>; they indicate the IC<sub>50</sub> of extract of stems of <italic>C</italic>. <italic>batesii</italic> and the percentage of growth inhibition against Dd2 and 7G8 <italic>P. falciparum</italic> strains respectively.<fig id="Fig3"><label>Fig. 3</label><caption><p>Result of twofold dose response analysis of the extract of <italic>C</italic>. <italic>batesii</italic> against Dd2 <italic>P</italic>. <italic>falciparum</italic> strain (<bold>a</bold>). Inhibition percentage of stems of <italic>C</italic>. <italic>batesii</italic> and isolated compounds against <italic>P. falciparum</italic> Dd2 strain (<bold>b</bold>). Inhibition percentage of stems of <italic>C</italic>. <italic>batesii</italic> and isolated compounds against <italic>P. falciparum</italic> 7G8 strain (<bold>c</bold>)</p></caption><graphic xlink:href="13065_2021_742_Fig3_HTML" id="MO3"/></fig></p><p id="Par13">Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a mentioned that the MeOH extract of stems discloses an IC<sub>50</sub>&#x02009;=&#x02009;50&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> against Dd2 <italic>P</italic>. <italic>falciparum</italic> strain which can be considered as a moderate activity. It appears from Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b that, apart from artemisinin (95.75% of inhibition) used as reference, the MeOH extract has the highest antiplasmodial activity with 88.24% percentage inhibition followed by <bold>2</bold> with approximately 78% of growth inhibition against Dd2 strain. Compounds <bold>3</bold> and <bold>5</bold> showed high activity (&#x0003e;&#x02009;65%) of inhibition, exhibiting a growth inhibition of Dd2 strain <italic>P. falciparum</italic> with percentages corresponding to 66.43% and 72.99% respectively.</p><p id="Par14">When tested against 7G8 <italic>P. falciparum</italic> strain, MeOH extract and compounds <bold>2</bold>, <bold>3</bold> and <bold>5</bold> displayed the percentages of growth inhibition of 18.82%, 34.26%, 10.04% and 2.84% at 10&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> respectively. The same extract and isolated compounds at 100&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> unveiled 25.03%, 63.86%, 98.07% and &#x02212;&#x000a0;18.44% of percentages of growth inhibition. These results are summarized in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>c and admit that <bold>2</bold> and <bold>3</bold> present the highest inhibition percentage (&#x0003e;&#x02009;60%) on 7G8 <italic>P. falciparum</italic> strains.</p><p id="Par15">From the antimycobacterial tests results (Table <xref rid="Tab2" ref-type="table">2</xref>), it should be noticed that the mixture of FA (A<sub>1</sub>) exhibited a good antitubercular activity with a Minimal Inhibitory Concentration (MIC) value at 9.52&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>. According to Cantrell et al. [<xref ref-type="bibr" rid="CR47">47</xref>], isolated compounds that exhibit a MIC&#x02009;&#x02264;&#x02009;64&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> are considered promising. For crude extracts, the MIC should be &#x02264;&#x02009;125&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> [<xref ref-type="bibr" rid="CR48">48</xref>]. The extract made known poor inhibitory activity against <italic>M</italic>ycobacterium <italic>tuberculosis</italic>, exhibiting a MIC and a Minimal Bactericidal Concentration (MBC) of 1250 and 2500&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> respectively.<table-wrap id="Tab2"><label>Table 2</label><caption><p>MIC and MBC values of the methanol extract and the mixture of fatty acids (A<sub>1</sub>) against <italic>Mycobacterium tuberculosis</italic> (AC 45)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Plant species</th><th align="left">MIC<sup>a</sup> (&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>)</th><th align="left">MBC<sup>b</sup> (&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>)</th><th align="left">MBC/MIC</th></tr></thead><tbody><tr><td align="left"><italic>C. batesii</italic></td><td align="left">1250</td><td align="left">2500</td><td align="left">2</td></tr><tr><td align="left">A<sub>1</sub></td><td align="left">9.52</td><td align="left">38.25</td><td align="left">4</td></tr><tr><td align="left">RMP</td><td align="left">0.97</td><td align="left">7.81</td><td align="left">8</td></tr></tbody></table><table-wrap-foot><p><italic>RMP</italic>&#x02009;Rifampicin</p><p><sup>a</sup>Minimum inhibitory concentration</p><p><sup>b</sup>Minimum bactericidal concentration</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec6"><title>Computational results of compound 2</title><p id="Par16">The structure of compound <bold>2</bold> was assigned based on spectroscopic analyses including, UV, IR, <sup>1</sup>H- and <sup>13</sup>C-NMR, 1D and 2D techniques. To get supplementary detailed awareness into the structure, DFT calculations were completed. The structure of the compound with the right stereochemistry was firstly optimized at B3LYP method using 6-31G(d) basis set and the optimized structure was submitted to a relaxed scan around one H&#x02013;C(5)&#x02013;N(6)&#x02013;H dihedral angle. Secondly, an additional relaxed scan around the other H&#x02013;C(5)&#x02013;N(6)&#x02013;H dihedral angle (with no change in basis set) was applied on a conformer with low energy got from the preceding step. The desired conformer still with low energy was thereafter subjected to two relaxed scans around the C(5)&#x02013;N(6)&#x02013;C(7)&#x02013;N(6) dihedral angles. All these scans led to an optimized geometry for <bold>2</bold>, based on the <italic>cis</italic>-relationship between H&#x02013;C(5)&#x02013;N(6)&#x02013;H (<sup>3</sup><italic>&#x000a0;J</italic>(H,H)&#x02009;=&#x02009;2.0&#x000a0;Hz). It is shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> and takes in account previous reports on <bold>1</bold> [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. The five membered ring is almost planar as observed in the case of allantoin (<bold>1</bold>) [<xref ref-type="bibr" rid="CR19">19</xref>].<fig id="Fig4"><label>Fig. 4</label><caption><p><bold>a</bold> ORTEP diagram of allantoin (<bold>1</bold>) [<xref ref-type="bibr" rid="CR44">44</xref>]; optimized geometry of batesiin (<bold>2</bold>) at <bold>b</bold> B3LYP/6-31G(d) and <bold>c</bold> B3LYP/6-31++G(d,p)</p></caption><graphic xlink:href="13065_2021_742_Fig4_HTML" id="MO4"/></fig></p><p id="Par17">The HOMO and LUMO of compound <bold>2</bold> (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>) as other descriptors were analyzed at B3LYP/6-31G(d) and 6-311G++(d,p) and compared with those of allantoin (<bold>1</bold>). The calculated HOMO&#x02013;LUMO gap was 6.209&#x000a0;eV; results are summarized in Table <xref rid="Tab3" ref-type="table">3</xref>.<fig id="Fig5"><label>Fig. 5</label><caption><p>HOMO (<bold>a</bold>) and LUMO (<bold>b</bold>) of <bold>2</bold>, calculated at B3LYP/6-311G++(d,p). The orbitals are plotted at isodensity of 0.02. The green color indicates the positive values of the phase while the negative values are characterized by the red color</p></caption><graphic xlink:href="13065_2021_742_Fig5_HTML" id="MO5"/></fig><table-wrap id="Tab3"><label>Table 3</label><caption><p>Some electronic and thermodynamic results of batesiin (<bold>2</bold>) compared to data of allantoin (<bold>1</bold>) at B3LYP</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Parameters</th><th align="left">Allantoin (<bold>1</bold>) [<xref ref-type="bibr" rid="CR19">19</xref>]</th><th align="left" colspan="2">Batesiin (<bold>2</bold>)</th></tr><tr><th align="left">B3LYP/6-311G++(d,p)</th><th align="left">B3LYP/6-31G(d)</th><th align="left">B3LYP/6-311G++(d,p)</th></tr></thead><tbody><tr><td align="left">SCF energy (a.u.)</td><td char="." align="char">&#x02212;&#x000a0;600.96805371</td><td char="." align="char">&#x02212;&#x000a0;976.275521823</td><td char="." align="char">&#x02212;&#x000a0;976. 58,639,012</td></tr><tr><td align="left">Zero point vibrational energy (kcal&#x000a0;mol<sup>&#x02212;1</sup>)</td><td char="." align="char">77.961</td><td char="." align="char">117.242</td><td char="." align="char">116.472</td></tr><tr><td align="left" rowspan="3"><italic>Rotational constants (GHz)</italic></td><td char="." align="char">1.876</td><td char="." align="char">0.713</td><td char="." align="char">0.721</td></tr><tr><td char="." align="char">0.876</td><td char="." align="char">0.262</td><td char="." align="char">0.257</td></tr><tr><td char="." align="char">0.754</td><td char="." align="char">0.261</td><td char="." align="char">0.254</td></tr><tr><td align="left" rowspan="3"><italic>Rotational temperatures (Kelvin)</italic></td><td char="." align="char">0.090</td><td char="." align="char">0.034</td><td char="." align="char">0.035</td></tr><tr><td char="." align="char">0.042</td><td char="." align="char">0.013</td><td char="." align="char">0.012</td></tr><tr><td char="." align="char">0.036</td><td char="." align="char">0.013</td><td char="." align="char">0.012</td></tr><tr><td align="left">Total energy (thermal) (kcal mol<sup>&#x02212;1</sup>)</td><td char="." align="char">84.462</td><td char="." align="char">127.176</td><td char="." align="char">126.495</td></tr><tr><td align="left">Molar heat capacity at constant volume, c<sub>v</sub> (cal mol<sup>&#x02212;1</sup>&#x000a0;K<sup>&#x02212;1</sup>)</td><td char="." align="char">37.756</td><td char="." align="char">58.872</td><td char="." align="char">59.237</td></tr><tr><td align="left">Molar heat capacity at constant pressure, c<sub>p</sub> (cal mol<sup>&#x02212;1</sup>&#x000a0;K<sup>&#x02212;1</sup>)</td><td char="." align="char">39.744</td><td char="." align="char">60.86</td><td char="." align="char">61.225</td></tr><tr><td align="left">Total entropy, S (cal mol<sup>&#x02212;1</sup>&#x000a0;K<sup>&#x02212;1</sup>)</td><td char="." align="char">100.186</td><td char="." align="char">129.784</td><td char="." align="char">130.265</td></tr><tr><td align="left">Total enthalpy, H (kcal mol<sup>&#x02212;1</sup>)</td><td char="." align="char">85.055</td><td char="." align="char">127.769</td><td char="." align="char">127.088</td></tr><tr><td align="left" colspan="4">Frontier MO energies (eV)</td></tr><tr><td align="left"><italic>&#x000a0;E</italic><sub><italic>LUMO</italic></sub></td><td char="." align="char">&#x02212;&#x000a0;1.196</td><td char="." align="char">&#x02212;&#x000a0;0.647</td><td char="." align="char">&#x02212;&#x000a0;1.440</td></tr><tr><td align="left"><italic>&#x000a0;E</italic><sub><italic>HOMO</italic></sub></td><td char="." align="char">&#x02212;&#x000a0;7.456</td><td char="." align="char">&#x02212;&#x000a0;7.149</td><td char="." align="char">&#x02212;&#x000a0;7.649</td></tr><tr><td align="left"><italic>&#x000a0;E</italic><sub><italic>LUMO</italic></sub>&#x02013;<italic>E</italic><sub><italic>HOMO</italic></sub></td><td char="." align="char">6.260</td><td char="." align="char">6.502</td><td char="." align="char">6.209</td></tr><tr><td align="left" colspan="4">Global reactivity descriptors</td></tr><tr><td align="left">&#x000a0;Ionization potential, <italic>IP</italic> (<italic>eV</italic>)</td><td char="." align="char">7.456</td><td char="." align="char">7.149</td><td char="." align="char">7.649</td></tr><tr><td align="left">&#x000a0;Electron affinity, <italic>EA</italic> (<italic>eV</italic>)</td><td char="." align="char">1.196</td><td char="." align="char">0.647</td><td char="." align="char">1.440</td></tr><tr><td align="left">&#x000a0;Electronegativity, <italic>&#x003c7;</italic></td><td char="." align="char">4.326</td><td char="." align="char">3.898</td><td char="." align="char">4.544</td></tr><tr><td align="left">&#x000a0;Chemical potential, <italic>&#x003bc;</italic></td><td char="." align="char">&#x02212;&#x000a0;4.326</td><td char="." align="char">&#x02212;&#x000a0;3.898</td><td char="." align="char">&#x02212;&#x000a0;4.544</td></tr><tr><td align="left">&#x000a0;Hardness, <italic>&#x003b7;</italic></td><td char="." align="char">3.130</td><td char="." align="char">3.251</td><td char="." align="char">3.104</td></tr><tr><td align="left">&#x000a0;Softness, <italic>S</italic></td><td char="." align="char">0.160</td><td char="." align="char">0.154</td><td char="." align="char">0.161</td></tr></tbody></table><table-wrap-foot><p>The values are calculated in gas phase (at 298.15&#x000a0;K)</p></table-wrap-foot></table-wrap></p><p id="Par18">The <sup>1</sup>H- and <sup>13</sup>C-NMR spectra of compound <bold>2</bold> were experimentally measured in DMSO-<italic>d</italic><sub>6</sub> on 500 and 125&#x000a0;MHz spectrometers respectively. The theoretical NMR were calculated at B3LYP/6-31G(d,p) and MPW1PW91/6-31+G(d,p) in DMSO. The chemical shifts were also simulated at B3LYP/6-31G(d), B3LYP/6-31+G(d,p), MPW1PW91/6-31G(d) and MPW1PW91/6-31G(d,p); however, the correlation with the experiment was relatively weak. GIAO (Gauge Invariant Atomic Orbital) formalism was used during these calculations, and the solvent effect was introduced through polarizable continuum model (PCM) by applying integral equation formalism (IEF). A comparison of the theoretical <sup>13</sup>C-NMR values at B3LYP/6-31G(d,p) and MPW1PW91/6-31+G(d,p) with the experimental ones is given in Table <xref rid="Tab4" ref-type="table">4</xref>. A better correlation with the experiment can be achieved if a scaling factor is applied to the <sup>13</sup>C-NMR theoretical values.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Experimental and calculated [at B3LYP/6-31G(d,p) and MPW1PW91/6-31+G(d,p)] <sup>13</sup>C-NMR data of <bold>1</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Position</th><th align="left" colspan="3"><sup>13</sup>C chemical shifts (ppm)</th></tr><tr><th align="left">Experimental</th><th align="left">B3LYP/6-31G(d,p)</th><th align="left">MPW1PW91/6-31+G(d,p)</th></tr></thead><tbody><tr><td align="left">2</td><td char="." align="char">156.8</td><td char="." align="char">156.1</td><td char="." align="char">157.0</td></tr><tr><td align="left">4</td><td char="." align="char">173.6</td><td char="." align="char">174.4</td><td char="." align="char">174.6</td></tr><tr><td align="left">5</td><td char="." align="char">62.4</td><td char="." align="char">61.7</td><td char="." align="char">62.7</td></tr><tr><td align="left">7</td><td char="." align="char">157.4</td><td char="." align="char">157.0</td><td char="." align="char">158.0</td></tr></tbody></table></table-wrap></p><p id="Par19">UV&#x02013;visible spectrum of <bold>1</bold> displayed three maxima at &#x003bb;<sub>max</sub> 183, 195&#x000a0;nm (representing the absorption bands of amide and imide functions) [<xref ref-type="bibr" rid="CR19">19</xref>] and 265&#x000a0;nm [<xref ref-type="bibr" rid="CR44">44</xref>]. Despite on the fact that batesiin (<bold>2</bold>) is characterized by the same chromophore groups, its UV&#x02013;visible spectrum (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) exhibits one major absorption band at &#x003bb;<sub>max</sub>&#x02009;=&#x02009;296&#x000a0;nm and minor absorptions as shoulder sections (letters A and B) with &#x003bb;<sub>max</sub> around 287 and 304&#x000a0;nm respectively. Simulated UV&#x02013;visible spectra of <bold>2</bold> were achieved at B3LYP/6-31+G(d,p) with chloroform (non-polar aprotic solvent) and ethanol (polar protic solvent) (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>), based on its tautomeric and ionic forms (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>): all &#x003bb;<sub>max</sub> results (experimental and theoretical) are summarized in Table <xref rid="Tab5" ref-type="table">5</xref>. Excitation energy (in nm) determined in CHCl<sub>3</sub> at 283.89 is closed to experimental value at 287&#x000a0;nm while simulation in EtOH exhibits an energy (in nm) at 315.59 which is comparable to the experimental &#x003bb;<sub>max</sub> at 304&#x000a0;nm. It must also be precised that results of IR calculations were almost similar to previous ones regarding allantoin (<bold>1</bold>) [<xref ref-type="bibr" rid="CR19">19</xref>], since <bold>1</bold> and <bold>2</bold> share the same functional groups; hence, there was no need to report them.<fig id="Fig6"><label>Fig. 6</label><caption><p>UV&#x02013;visible spectra of <bold>2</bold> in chloroform (<bold>a</bold>) and in ethanol (<bold>b</bold>), calculated at B3LYP/6-31G+(d,p)</p></caption><graphic xlink:href="13065_2021_742_Fig6_HTML" id="MO6"/></fig><fig id="Fig7"><label>Fig. 7</label><caption><p>Tautomeric and ionic forms of <bold>2</bold>; based on UV&#x02013;visible results, it seems most likely that the (<bold>C</bold>) form should be the major one</p></caption><graphic xlink:href="13065_2021_742_Fig7_HTML" id="MO7"/></fig><table-wrap id="Tab5"><label>Table 5</label><caption><p>Main experimental and vertical excitation energies of batesiin (<bold>2</bold>) along with oscillator strengths and transitions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Experimental</th><th align="left" colspan="2">Excitation energy (nm)</th><th align="left" colspan="2">Oscillator strength</th><th align="left" colspan="2">Electronic transition</th></tr><tr><th align="left"/><th align="left">CHCl<sub>3</sub></th><th align="left">EtOH</th><th align="left">CHCl<sub>3</sub></th><th align="left">EtOH</th><th align="left">CHCl<sub>3</sub></th><th align="left">EtOH</th></tr></thead><tbody><tr><td align="left">287</td><td char="." align="char">283.89</td><td char="." align="char">270.11</td><td char="." align="char">0.0025</td><td char="." align="char">0.0026</td><td align="left"><sup>a</sup>H&#x02013;2&#x02009;&#x02192;&#x02009;<sup>b</sup>L&#x02009;+&#x02009;1</td><td align="left"><sup>a</sup>H&#x02013;2&#x02009;&#x02192;&#x02009;<sup>b</sup>L&#x02009;+&#x02009;1</td></tr><tr><td align="left">296</td><td char="." align="char">299.01</td><td char="." align="char">289.70</td><td char="." align="char">0.0171</td><td char="." align="char">0.0153</td><td align="left"><sup>a</sup>H&#x02013;3&#x02009;&#x02192;&#x02009;<sup>b</sup>L</td><td align="left"><sup>b</sup>H&#x02013;3&#x02009;&#x02192;&#x02009;<sup>b</sup>L</td></tr><tr><td align="left">304</td><td char="." align="char">327.69</td><td char="." align="char">315.59</td><td char="." align="char">0.0084</td><td char="." align="char">0.0079</td><td align="left"><sup>a</sup>H&#x02013;1&#x02009;&#x02192;&#x02009;<sup>b</sup>L</td><td align="left"><sup>a</sup>H&#x02013;1&#x02009;&#x02192;&#x02009;<sup>b</sup>L</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>H: HOMO</p><p><sup>b</sup>L: LUMO</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec7"><title>Discussion</title><p id="Par20">NMR data summarized in Table <xref rid="Tab3" ref-type="table">3</xref> strengthen the close relationship between allantoin (<bold>1</bold>) and batesiin (<bold>2</bold>), their <sup>13</sup>C chemical shifts being almost analogous (Table <xref rid="Tab1" ref-type="table">1</xref>). The main difference relies on <sup>1</sup>H NMR spectra of both compounds: in <bold>1</bold>, a value at &#x003b4;<sub>H</sub> 5.23 (1H, H&#x02013;C(5)) ppm [<xref ref-type="bibr" rid="CR50">50</xref>] is equivalent to chemical shift in <bold>2</bold> at &#x003b4;<sub>H</sub> 5.30 (2H, d<italic>, </italic><sup><italic>3</italic></sup><italic>&#x000a0;J</italic>(H,H)&#x02009;=&#x02009;2.0&#x000a0;Hz, H&#x02013;C(5)) ppm. This 0.7&#x000a0;ppm variation between the aforesaid chemical shifts could be explained by the conformation of <bold>2</bold> (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b, c) which seems to induce deshielding of the hydrogen atoms located on carbons C(5).</p><p id="Par21">Results from bioassays against 7G8 <italic>P. falciparum</italic> strain reveal that an increase in concentration (10 to 100&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>) marks an increase in percentages of inhibition for MeOH extract, <bold>2</bold> and <bold>3</bold>, but a decrease (with a negative percentage) for <bold>5</bold>, which should indicate that the latter is totally inactive at high concentrations. The moderate activity of the MeOH extract suggests insufficient synergistic or additive effects of potential antiplasmodial secondary metabolites from <italic>C</italic>. <italic>batesii</italic>. In contrast to the mixture of FA, the weak antimycobacterial properties of the crude extract suggest the occurrence within <italic>C. batesii</italic> of components with very poor antimycobacterial effects (Table <xref rid="Tab2" ref-type="table">2</xref>). Moreover, a report from literature indicates that mycobacteria have a lipid-rich hydrophobic cell wall and are often susceptible to less polar compounds [<xref ref-type="bibr" rid="CR51">51</xref>]. According to Peterson and Shanholtzer [<xref ref-type="bibr" rid="CR52">52</xref>], bacteriostatic activity has been defined as a ratio of MBC to MIC of &#x0003e;&#x02009;4. Hence, essential oil exhibited bacteriostatic activity.</p><p id="Par22">The high value of the HOMO&#x02013;LUMO band gap is indicative of a relative stability of the molecule towards oxidation&#x02013;reduction reactions. However, it is less than the HOMO&#x02013;LUMO band gap of allantoin (<bold>1</bold>) (see Table <xref rid="Tab3" ref-type="table">3</xref>) at the same method, maybe as an expression of additional stability of <bold>2</bold> and difference in biological behavior between both chemical entities. Plots of frontier orbitals show that HOMOs and LUMOs are globally focused over the entire molecule. Meanwhile, in the case of HOMOs, the ureidyl moiety is less concerned by the orbital overlap whereas it is recognized as the area covering the positive phase in LUMOs (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). The theoretical <sup>13</sup>C-NMR values are, on the average, higher than the experimental ones when using MPW1PW91/6-31+G(d,p); by contrast, it is not the same observation with results provided by the B3LYP/6-31G(d,p) process. Regardless of the difference in the absolute values, the theoretical values match nicely with the experimental data. Based on the simulated UV&#x02013;visible spectrum, batesiin (<bold>2</bold>) should most likely appear as an intermediate between various iminols and iminolates groups, precisely due to additional stability as already hypothesized (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>). Two free protons are supposed to be located somewhere between, in each case, a nitrogen and an anionic oxygen of the same iminolate group, at a site however nearer to oxygen (distance&#x02009;&#x0003c;&#x02009;1.4&#x000a0;&#x001fa;) than to nitrogen (distance&#x02009;&#x0003e;&#x02009;2.3&#x000a0;&#x001fa;) (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>). Hence, a virtual loss of symmetry becomes noticeable within <bold>2</bold>, inducing a change in MOs with an impact on electronic transitions (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>). LUMO and LUMO&#x02009;+&#x02009;1 are localized on one imidazole fragment (especially in the region covering a free proton and the anionic oxygen located in its neighborhood) when the other one looks totally unoccupied. Moving from HOMO-1 to HOMO-3 causes an increase in orbital overlap within the entire chemical entity. Table <xref rid="Tab5" ref-type="table">5</xref> expresses the nature of electronic transitions which are in agreement with the corresponding &#x003bb;<sub>max</sub>, depending on the nature of the solvent.<fig id="Fig8"><label>Fig. 8</label><caption><p>One case of simulated "iminol"/"iminolate" form of <bold>2</bold> with distances between protons and nitrogen or oxygen atoms at B3LYP/6-31G+(d,p); this form seems to induce the electronic transitions (in nm)</p></caption><graphic xlink:href="13065_2021_742_Fig8_HTML" id="MO8"/></fig><fig id="Fig9"><label>Fig. 9</label><caption><p>Various MOs of <bold>2</bold> involved in electronic transitions, at B3LYP/6-31G+(d,p). The green color represents the positive values of the phase while the red color is indicative of its negative values</p></caption><graphic xlink:href="13065_2021_742_Fig9_HTML" id="MO9"/></fig></p></sec><sec id="Sec8"><title>Conclusion</title><p id="Par23">Batesiin (<bold>2</bold>) has been characterized for the first time by means of <sup>1</sup>H-, <sup>13</sup>C-NMR and UV spectroscopies; its structure was confirmed by DFT and TD-DFT calculations at B3LYP/6-31G(d,p), 6-31G+(d,p), 6-311G++(d,p) and MPW1PW91/6-31G+(d,p) from this study. The MeOH crude extract of the stems showed a moderate activity against Dd2 <italic>P</italic>. <italic>falciparum</italic> strain with IC<sub>50</sub>&#x02009;=&#x02009;50&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>. The antiplasmodial properties of <bold>2</bold> and some other compounds are deduced from high percentages of growth inhibition against the 7G8 <italic>P</italic>. <italic>falciparum</italic> strain; in parallel, antimycobacterial activities against <italic>M</italic>. <italic>tuberculosis</italic> arise from the essential oil equivalent to the mixture of FA (<bold>9</bold>&#x02013;<bold>14</bold>) with a MIC&#x02009;=&#x02009;9.52&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>. Additional data corresponding to HOMO, LUMO, enthalpy, entropy or some reactivity descriptors like <italic>IP</italic> or <italic>EA</italic> were also simulated, this time at B3LYP/6-31G(d) and 6-311G++(d,p) and compared with data from literature of allantoin (<bold>1</bold>) [<xref ref-type="bibr" rid="CR19">19</xref>]; moreover, no comparison with the experiment in this case could be made. This work supports a good agreement between experimental data and DFT calculations in case of structure elucidation. These preliminary results also support the hypothesis of further development of new antimalarial and antitubercular drugs from the genus <italic>Cordia</italic>.</p></sec><sec id="Sec9"><title>Methods</title><sec id="Sec10"><title>General</title><p id="Par24">Melting points were uncorrected and were measured on a Mettler Toledo instrument. IR spectra were recorded on an Alpha II FT-IR spectrometer from Bruker in the region of 4000&#x02013;600&#x000a0;cm<sup>&#x02013;1</sup>, using KBr pellet technique with 1.0&#x000a0;cm<sup>&#x02013;1</sup> resolution at room temperature. 1D and 2D NMR spectra were obtained on a Bruker DRX 500 (500&#x000a0;MHz for <sup>1</sup>H and 125&#x000a0;MHz for <sup>13</sup>C spectra) spectrometer (Bruker, Rheinstetten, Germany) with chemical shifts reported as &#x003b4; (ppm), using TMS as an internal standard. The ESI-MS were obtained on LTQ-FT instrument (Thermo Scientific). LC&#x02013;MS were measured with Shimadzu LC&#x02013;MS system using a L-column 2 ODS (I.D. 2.1&#x02009;&#x000d7;&#x02009;100&#x000a0;mm, Chemical Evaluation and Research Institute, Japan), at a flow rate of 0.2&#x000a0;mL&#x000a0;min<sup>&#x02212;1</sup> with a detection wavelength of 300&#x000a0;nm and FMW (HCOOH/MeCN/H<sub>2</sub>O&#x02009;=&#x02009;1:12:87) as eluent, ESI+&#x02009;4.5&#x000a0;kV, ESI&#x02212;&#x02009;3.5&#x000a0;kV, 250&#x000a0;&#x000b0;C. Optical rotations were measured on a Perkin-Elmer 341 polarimeter. Silica gel 60 (230&#x02013;400 mesh E. Merck, Darmstadt, Germany) and <italic>Sephadex</italic><sup>&#x000ae;</sup> LH-20 were employed for CC, the solvent mixing systems for elution were mainly CH<sub>2</sub>Cl<sub>2</sub>/MeOH for the phytochemical study with increasing polarity and pure MeOH, while precoated aluminum sheets silica gel 60 F254 were used for TLC [<xref ref-type="bibr" rid="CR53">53</xref>].</p></sec><sec id="Sec11"><title>Plant material</title><p id="Par25">The plant material was collected on March 2014 at Koumoul in center region of Cameroon. The identity of plant material was confirmed by the taxonomist Victor Nana. A voucher sample (14,106 SRF) is deposited at the National Herbarium of Cameroon, Yaounde.</p></sec><sec id="Sec12"><title>Extraction and isolation</title><p id="Par26">The stems were dried in shade and cut into small pieces and then submitted for further studies. 80% of air dried pieces of stems of <italic>C</italic>. <italic>batesii</italic> (500&#x000a0;g) were extracted with MeOH (5&#x02009;&#x000d7;&#x02009;500&#x000a0;mL, 30&#x000a0;min each) using an Elma<sup>&#x000ae;</sup> sonic S 100 at r. t. The extract was filtered; the filtrate was evaporated to dryness in a Rotavapor. The residue obtained from the MeOH extract (about 53&#x000a0;g) was dissolved into hexane&#x02013;water 80:20 (100&#x000a0;mL) during 1&#x000a0;day; the resulting hexane&#x02013;water gum (42&#x000a0;g) was dissolved in a mixture of CHCl<sub>3</sub>&#x02013;H<sub>2</sub>O 80:20 (100&#x000a0;mL) once again in a period of 24&#x000a0;h; the resulting CHCl<sub>3</sub>&#x02013;H<sub>2</sub>O extract (36&#x000a0;g) was dissolved in CH<sub>3</sub>COOH&#x02013;H<sub>2</sub>O 70:30 (100&#x000a0;mL) during 24&#x000a0;h. The final extract (26&#x000a0;g) was submitted to further CC analyses. The crude MeOH extract (26&#x000a0;g) was subjected to CC of LH-20 (2.5&#x000a0;cm, 50&#x000a0;cm, eluent MeOH). Four main fractions were obtained: A (10.36&#x000a0;g), B (4.6&#x000a0;g), C (3.0&#x000a0;g) and D (7.0&#x000a0;g). Fraction A (10.36&#x000a0;g) was subjected to a silica gel CC (1.8&#x000a0;cm, 3&#x02009;&#x000d7;&#x02009;50&#x000a0;cm, eluent CH<sub>2</sub>Cl<sub>2</sub>&#x02013;MeOH 100&#x02013;1:1) and provided three sub-fraction (A<sub>1</sub>, A<sub>2</sub>, and A<sub>3</sub>). Sub-fraction A<sub>2</sub> (5.20&#x000a0;g) was fractionated by silica gel CC (1.8&#x000a0;cm, 3&#x02009;&#x000d7;&#x02009;50&#x000a0;cm, eluent CH<sub>2</sub>Cl<sub>2</sub>&#x02013;MeOH 50:1&#x02013;30:1) to produce two compounds, <bold>4</bold> (4.6&#x000a0;mg) and <bold>5</bold> (11&#x000a0;mg). Fraction B (4.6&#x000a0;g) was chromatographed as described above to give five sub-fractions (B<sub>1</sub>, B<sub>2</sub>, B<sub>3</sub>, B<sub>4</sub> and B<sub>5</sub>). Sub-fraction B<sub>1</sub> (0.20&#x000a0;g) was purified by silica gel CC (1.8&#x000a0;cm, 3&#x02009;&#x000d7;&#x02009;50&#x000a0;cm, eluent CH<sub>2</sub>Cl<sub>2</sub>&#x02013;MeOH 30:1&#x02013;20:1) to yield compound <bold>1</bold> (9&#x000a0;mg). Compound <bold>2</bold> (7.5&#x000a0;mg) was isolated from sub-fraction B<sub>3</sub> (0.31&#x000a0;g) using a silica gel CC (1.8&#x000a0;cm, 3&#x02009;&#x000d7;&#x02009;50&#x000a0;cm, eluent CH<sub>2</sub>Cl<sub>2</sub>&#x02013;MeOH 40:1&#x02013;20:1). Sub-fraction B<sub>4</sub> (0.60&#x000a0;g) was fractionated and purified using a silica gel CC (1.8&#x000a0;cm, 3&#x02009;&#x000d7;&#x02009;50&#x000a0;cm, eluent CH<sub>2</sub>Cl<sub>2</sub>&#x02013;MeOH 40:1&#x02013;15:1) to provide <bold>3</bold> (4&#x000a0;mg). The essential oil (sub-fraction A<sub>1</sub>, 0.60&#x000a0;g) resulting from the crude extract was analyzed by LC&#x02013;MS, exhibiting compounds <bold>6</bold>, <bold>7</bold> and <bold>8</bold>. A<sub>1</sub> was soluble in pure hexane and crystallized from pure CH<sub>2</sub>Cl<sub>2</sub>. 487&#x000a0;mg were analyzed by GC&#x02013;MS which revealed the compounds <bold>9</bold>, <bold>10</bold>, <bold>11</bold>, <bold>12</bold>, <bold>13</bold> and <bold>14</bold>.</p></sec><sec id="Sec13"><title>Characteristics of compound 2</title><p id="Par27">Batesiin (<bold>2</bold>), white solid: mp 231&#x02013;233&#x000a0;&#x000b0;C. TLC (CH<sub>2</sub>Cl<sub>2</sub>:MeOH, 20:1 v/v) R<sub>f</sub>&#x02009;=&#x02009;0.6; <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${[\mathrm{\alpha }]}_{\mathrm{D}}^{20}$$\end{document}</tex-math><mml:math id="M2"><mml:msubsup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>&#x003b1;</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mn>20</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="13065_2021_742_Article_IEq1.gif"/></alternatives></inline-formula> = &#x02212;&#x000a0;98.3&#x000b0; (0.04&#x000a0;M in acetone). <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 10.51 (2H, s, NH), 8.04 (2H, s, NH), 6.88 (2H, d, J&#x02009;=&#x02009;2&#x000a0;Hz, NH), 5.23 (2H, d, J&#x02009;=&#x02009;2&#x000a0;Hz); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 62.4, 156.8, 157.4, 173.6; IR (KBr) cm<sup>&#x02013;1</sup> 3425, 3340 (O&#x02013;H), 3125, 3060 (N&#x02013;H), 1810, 1740, 1680, 1560 (C=O); UV/Vis: &#x003bb;<sub>max</sub> (MeOH) nm: 296. HR-LC/MS (m/z): [M+Na]<sup>+</sup> calcd for C<sub>7</sub>H<sub>8</sub>N<sub>6</sub>O<sub>5</sub>Na<sup>+</sup>; 279.1608; found 279.1603; analysis (calcd., found for C<sub>7</sub>H<sub>8</sub>N<sub>6</sub>O<sub>5</sub>Na): C (30.12, 30.09); H (2.89, 2.85); N (30.10, 30.10); O (28.66, 28.65).</p></sec><sec id="Sec14"><title>Biological assays</title><sec id="Sec15"><title>In vitro cultivation of <italic>P</italic>. <italic>falciparum</italic> strains</title><p id="Par28"><italic>Pf</italic>Dd2 and <italic>Pf</italic>7G8 strains of <italic>P. falciparum</italic> were used in vitro in blood stage culture to test the antimalarial efficacy of MeOH extract of stems of <italic>C</italic>. <italic>batesii</italic> and isolated compounds <bold>2</bold>, <bold>3</bold> and <bold>5</bold>. The culture was maintained at the Laboratory of parasitology, Centre Pasteur du Cameroon. <italic>P. falciparum</italic> culture was maintained according to the method described by Trager and Jensen [<xref ref-type="bibr" rid="CR54">54</xref>] with slight modifications. <italic>P. falciparum</italic> Dd2 and 7G8 cultures were maintained in fresh O<sup>+ve</sup> human erythrocytes suspended at 4% haematocrit in RPMI 1640 (Sigma Aldrich&#x02014;France) containing 0.2% sodium bicarbonate, 0.5% Albumax, 45&#x000a0;&#x003bc;g&#x000a0;L<sup>&#x02212;1</sup> hypoxanthine and 50&#x000a0;&#x003bc;g&#x000a0;L<sup>&#x02212;1</sup> gentamicin, and incubated at 37&#x000a0;&#x000b0;C under a gas mixture 5% O<sub>2</sub>, 5% CO<sub>2</sub>, and 90% N<sub>2</sub>. Every day, infected erythrocytes were transferred into fresh complete medium to propagate the culture.</p></sec></sec><sec id="Sec16"><title>Drug dilutions</title><p id="Par29">Artemisinin (Sigma Aldrich&#x02014;France) and isolated compounds were prepared in DMSO. All stocks were then diluted with culture medium to achieve the required concentrations. The final solution of all plant extracts, isolated compounds and artemisinin contained 0.4% DMSO, which was found to be non-toxic to the parasites. Drugs and test compounds were then placed in 96-well flat bottom tissue culture grade plates.</p></sec><sec id="Sec17"><title>Assay for antiplasmodial activity</title><p id="Par30">The stems of <italic>C</italic>. <italic>batesii</italic> were evaluated for their antimalarial activity against <italic>P. falciparum</italic> strains Dd2 and 7G8. For drug screening, SYBR green I-based fluorescence assay was setup as described by Smilkstein et al. [<xref ref-type="bibr" rid="CR46">46</xref>]. Sorbitol synchronized parasites were incubated under normal culture conditions at 2% haematocrit and 1% parasitemia in the absence or presence of increasing concentrations of MeOH extracts of <italic>C</italic>. <italic>batesii</italic>. Artemisinin was used as positive control, while 0.4% DMSO was used as the negative control. After 48&#x000a0;h of incubation, 100&#x000a0;&#x003bc;L of SYBR Green I solution [0.2&#x000a0;&#x003bc;L&#x000a0;mL<sup>&#x02212;1</sup> of 10,000&#x000d7; SYBR Green I (Sigma Aldrich&#x02014;France)] in lysis buffer [Tris (20&#x000a0;mM; pH 7.5), EDTA (5&#x000a0;mM), saponin (0.008%; w/v) and Triton X-100 (0.08%; v/v)] was added to each well. The microtiter plate was mixed twice gently with multi-channel pipette and incubated in dark at 37&#x000a0;&#x000b0;C for 1&#x000a0;h. Fluorescence was measured with a fluorescence multi-well plate reader (Perkin Elmer) with excitation and emission wavelength bands centred at 485 and 530&#x000a0;nm, respectively. The fluorescence counts were plotted against the drug concentration and the inhibitory percentage of each plant extract and compound was calculated using the following equation:<disp-formula id="Equa"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{I}}\left( \% \right) = \frac{{{\text{Abs}}_{{{\text{control}}}} - {\text{Abs}}_{{{\text{extracts}}/{\text{isolated compounds}}}} { }}}{{{\text{Abs}}_{{{\text{control}}}} }} \times 100$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mtext>I</mml:mtext><mml:mfenced close=")" open="("><mml:mo>%</mml:mo></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mtext>Abs</mml:mtext><mml:mtext>control</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mtext>Abs</mml:mtext><mml:mrow><mml:mtext>extracts</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mrow><mml:mtext>isolated compounds</mml:mtext></mml:mrow></mml:mrow></mml:msub><mml:mrow/></mml:mrow><mml:msub><mml:mtext>Abs</mml:mtext><mml:mtext>control</mml:mtext></mml:msub></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic xlink:href="13065_2021_742_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>where Abs<sub>control</sub> is the absorbance of untreated well and Abs<sub>extracts/isolated compounds</sub> is the absorbance of extracts or compounds well.</p></sec><sec id="Sec18"><title>Antimycobacterial tests</title><p id="Par31">For the present study, the mycobacterium (<italic>M. tuberculosis</italic>) used was a clinical isolated strain resistant to isoniazid codified as AC 45 (this strain was obtained from Sangmelima district&#x02019;s Hospital in south region of Cameroon). The genetical profile of the resistance has been carried out at Laboratory for Tuberculosis Research (Biotechnology Centre, University of Yaound&#x000e9; I) through Line probe Assay method. The mycobacteria strains have been cultured at 37&#x000a0;&#x000b0;C for 2&#x000a0;weeks in Middlebrook 7H9 (Himedia, India) supplemented with 0.05% (v/v), 2% glycerol and 10% OADC (oleic acid-albumin-dextrose-catalase of Liofilchem s.r.l, Italia). The optical density of 0.45 to 0.55 was measured using spectrophotometer at 550&#x000a0;nm to obtain a suspension of 1.5&#x02009;&#x000d7;&#x02009;108 UFC&#x000a0;mL<sup>&#x02212;1</sup>. The activity of all phytochemicals (extract and pure compounds) against the aforementioned <italic>M. tuberculosis</italic> strains was tested using the microplate Alamar Blue assay as described previously by Collins and Franzblau [<xref ref-type="bibr" rid="CR55">55</xref>]. In a 96 well microplates, all wells received 100&#x000a0;&#x003bc;L of supplemented Middlebrook 7H9 broth, then working metabolites solutions (100&#x000a0;&#x003bc;L) were poured into the first well of each row, from which twofold dilution series were made through the microplate column. The test inoculum (100&#x000a0;&#x003bc;L) was added to all testing wells, as well as to the drug-free control wells. The final concentration of DMSO in wells was 7% v/v. The final concentrations tested ranged from 250 to 0.244&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> for pure compounds and 5000 to 4.882&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> for extracts. Rifampicin was used as standard drug. Each concentration was assayed in triplicate. Each microplate was sealed with parafilm paper and incubated for 14&#x000a0;days at 37&#x000a0;&#x000b0;C. After that, 40 &#x003bc;L of Alamar blue solution was added to two columns of each triplicate in order to show mycobacterial growth and the plates were re-incubated at 37&#x000a0;&#x000b0;C for 24&#x000a0;h. After 1&#x000a0;day of incubation, the MIC was defined as the lowest concentration of phytochemicals that inhibited the bacterial growth (prevents a color change from blue to pink) after incubation time [<xref ref-type="bibr" rid="CR56">56</xref>]. For the MBC determination, 50&#x000a0;&#x003bc;L of each well which concentration was &#x02265;&#x02009;MIC was sub-cultured in 150&#x000a0;&#x003bc;L of Mbk 7H9 medium and incubated at 37&#x000a0;&#x000b0;C for 10&#x000a0;days, then mycobacterial growth was carried out by addition of 40&#x000a0;&#x003bc;L of alamar blue. MBC was defined as the lowest concentration of extract at which no visible growth of the germ was observed.</p></sec><sec id="Sec19"><title>Computational details</title><p id="Par32">All calculations were performed with Gaussian 09 suite of programs [<xref ref-type="bibr" rid="CR57">57</xref>] and UV&#x02013;visible curves were generated by GaussSum [<xref ref-type="bibr" rid="CR58">58</xref>]. Geometries were optimized at hybrid B3LYP method using 6-31G(d) basis set. The B3LYP mode provides a good balance between cost and precision [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. A preliminary predict of the geometry of compound <bold>2</bold> is based on the stereochemistry ascribed through 1D and 2D NMR characterizations. Compound <bold>2</bold> has conformational flexibility around the symmetric dihedral angles H&#x02013;C(5)&#x02013;N(6)&#x02013;H and C(5)&#x02013;N(6)&#x02013;C(7)&#x02013;N(6). The dihedral angles around the C(5)&#x02013;N(6) axes were scanned at 15 degrees step and a minimum at 22.9&#x000b0; around the C(5)&#x02013;N(6) axes was retained because of its conformation closed to the structure of allantoin (<bold>1</bold>). Afterwards, dihedral angles around the N(6)&#x02013;C(7) axes were scanned at 10 degrees step, to find the lowest energy conformer. It was then submitted to geometry optimization at B3LYP/6-31G(d) and B3LYP/6-311++G(d,p) levels of theory to provide the optimized geometries of <bold>2</bold> (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). The optimized structure was in each case confirmed by frequency analysis at the same levels as a true minimum (no imaginary frequency). Six methods were evaluated for the simulation of <sup>1</sup>H- and <sup>13</sup>C-NMR spectra; B3LYP/6-31G(d), B3LYP/6-31G(d,p), B3LYP/6-31G+(d,p), MPW1PW91/6-31G(d), MPW1PW91/6-31G(d,p) and MPW1PW91/6-31G+(d,p). The electronic properties at isodensity 0.02 such as Ionization Potential (<italic>IP</italic>), Electron Affinity (<italic>EA</italic>), HOMO, LUMO and band gaps were calculated at B3LYP/6-31G(d) and B3LYP/6-311G++(d,p). The band gap was taken as the difference in energies of HOMO and LUMO. Meantime, thermodynamic properties like enthalpy, entropy or molar capacity at constant volume along with reactivity descriptors like chemical potential, electronegativity, hardness, softness were also calculated by means of the same methods. TD-DFT studies were evaluated at B3LYP/6-31G+(d,p) in CHCl<sub>3</sub> and in EtOH after a geometry optimization at the same level of theory of the iminolate in Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>. Six steps were applied to get excitation energies.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Information</title><sec id="Sec20"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13065_2021_742_MOESM1_ESM.pdf"><caption><p><bold>Additional file 1.</bold> NMR spectra of compound <bold>2</bold>, some HMBC correlations, GC&#x02013;MS analyses of compounds <bold>9</bold>, <bold>10</bold>, <bold>11</bold>, <bold>12</bold>, <bold>13</bold> and <bold>14</bold>, LC&#x02013;MS and GC&#x02013;MS chromatograms of the extract of <italic>C</italic>. <italic>batesii</italic>, the ESI-MS spectrum of compound <bold>2</bold>, the genotype profile of <italic>M. tuberculosis</italic> codified AC 45, the shielding tensors of the nuclei of <bold>2</bold>, the electronic (HOMO, LUMO) properties, the cartesian coordinates of the optimized geometry of compound <bold>2</bold> and TD-DFT are available as additional file.</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Jos&#x000e9;phine Ngo Mbing and Dieudonn&#x000e9; Emmanuel Pegnyemb contributed equally to this work</p></fn></fn-group><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13065-021-00742-5.</p></sec><ack><title>Acknowledgements</title><p>We thank Mr. Victor Nana for the collection and identification of the plant material. We are indebted to Mr. Felix Fehr (Department of Chemistry, University of Fribourg) and to Koert&#x02019;s group (Philipps-Universitat Marburg) for spectral analyses; we also thank the German cooperation through the DAAD/YaBiNaPa program for running the LC&#x02013;MS analyses.</p></ack><notes notes-type="author-contribution"><title>Authors' contributions</title><p>ERT, NMN and PHBD performed the experiments, DSNB, IMN and AAAZ analyzed the data, conceived and designed the experiments and wrote the article. LA, BLN, JNM and DEP, contributed samples/reagents/materials/analysis tools and analyzed the data. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The authors acknowledge financial support from the Ministry of Higher Education, Cameroon and from the University of Yaounde I grant committee.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this published article (and its Additional file <xref rid="MOESM1" ref-type="media">1</xref>).</p></notes><notes><title>Declarations</title><notes><title>Ethics approval and consent to participate</title><p id="Par33">Not applicable.</p></notes><notes><title>Consent for publication</title><p id="Par34">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par35">The authors declare that they have no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">World Health Organization. Accelerating progress on HIV, tuberculosis, malaria, hepatitis and neglected tropical diseases: a new agenda for 2016&#x02013;2030. 2015. World Health Organization. <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/handle/10665/204419">https://apps.who.int/iris/handle/10665/204419</ext-link>. Accessed 15 Sept 2020.</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>C</given-names></name><name><surname>Nyunt</surname><given-names>MM</given-names></name><name><surname>Ringwald</surname><given-names>P</given-names></name></person-group><article-title>Artemisinin-resistant <italic>Plasmodium falciparum</italic> in Africa</article-title><source>N Engl J Med</source><year>2017</year><volume>377</volume><fpage>305</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1705789</pub-id><?supplied-pmid 28723327?><pub-id pub-id-type="pmid">28723327</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houben</surname><given-names>RM</given-names></name><name><surname>Dodd</surname><given-names>PJ</given-names></name></person-group><article-title>The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling</article-title><source>PLoS Med</source><year>2016</year><volume>13</volume><fpage>e1002152</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1002152</pub-id><?supplied-pmid 27780211?><pub-id pub-id-type="pmid">27780211</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Der Meeren</surname><given-names>OV</given-names></name><name><surname>Hatherill</surname><given-names>M</given-names></name><name><surname>Nduba</surname><given-names>V</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Muyoyeta</surname><given-names>M</given-names></name><name><surname>Van Brakel</surname><given-names>E</given-names></name><etal/></person-group><article-title>Phase 2b controlled trial of M72/AS01E vaccine to prevent tuberculosis</article-title><source>N Engl J Med</source><year>2018</year><volume>379</volume><fpage>1621</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1803484</pub-id><pub-id pub-id-type="pmid">30280651</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">World malaria report. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.</mixed-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>JA</given-names></name><name><surname>Acosta</surname><given-names>ME</given-names></name><name><surname>Gamboa</surname><given-names>ND</given-names></name><name><surname>Mijares</surname><given-names>MR</given-names></name><name><surname>De Sanctis</surname><given-names>JB</given-names></name><name><surname>Llovera</surname><given-names>LJ</given-names></name><name><surname>Charris</surname><given-names>JE</given-names></name></person-group><article-title>Synthesis, antimalarial, antiproliferative, and apoptotic activities of benzimidazole-5-carboxamide derivatives</article-title><source>Med Chem Res</source><year>2019</year><volume>28</volume><fpage>13</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1007/s00044-018-2258-x</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Otaibi</surname><given-names>JS</given-names></name><name><surname>Almuqrin</surname><given-names>AH</given-names></name><name><surname>Mary</surname><given-names>YS</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name></person-group><article-title>Modeling the conformational preference, spectroscopic properties, UV light harvesting efficiency, biological receptor inhibitory ability and other physico-chemical properties of five imidazole derivatives using quantum mechanical and molecular mechanics tools</article-title><source>J Mol Liq</source><year>2020</year><volume>310</volume><fpage>112871</fpage><lpage>112875</lpage><pub-id pub-id-type="doi">10.1016/j.molliq.2020.112871</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lodewyk</surname><given-names>MW</given-names></name><name><surname>Siebert</surname><given-names>MR</given-names></name><name><surname>Tantillo</surname><given-names>DJ</given-names></name></person-group><article-title>Computational Prediction of <sup>1</sup>H and <sup>13</sup>C chemical shifts: a useful tool for natural product, mechanistic, and synthetic organic chemistry</article-title><source>Chem Rev</source><year>2012</year><volume>112</volume><fpage>1839</fpage><lpage>1862</lpage><pub-id pub-id-type="doi">10.1021/cr200106v</pub-id><?supplied-pmid 22091891?><pub-id pub-id-type="pmid">22091891</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oza</surname><given-names>MJ</given-names></name><name><surname>Kulkarni</surname><given-names>YA</given-names></name></person-group><article-title>Traditional uses, phytochemistry and pharmacology of the medicinal species of the genus <italic>Cordia</italic> (Boraginaceae)</article-title><source>J Pharm Pharmacol</source><year>2017</year><volume>69</volume><fpage>755</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1111/jphp.12715</pub-id><?supplied-pmid 28266011?><pub-id pub-id-type="pmid">28266011</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barroso</surname><given-names>ICE</given-names></name><name><surname>de Oliveira</surname><given-names>F</given-names></name><name><surname>Ciarelli</surname><given-names>DM</given-names></name></person-group><article-title>Morphology of the dispersion unit and germination of <italic>Cordia sellowiana</italic> and <italic>Cordia myxa</italic></article-title><source>Bragantia</source><year>2009</year><volume>68</volume><fpage>241</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1590/S0006-87052009000100026</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioset</surname><given-names>JR</given-names></name><name><surname>Marston</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>MP</given-names></name><name><surname>Hostettmann</surname><given-names>K</given-names></name></person-group><article-title>Antifungal and larvicidal compounds from the root bark of <italic>Cordia alliodora</italic></article-title><source>J Nat Prod</source><year>2000</year><volume>63</volume><fpage>424</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1021/np990393j</pub-id><?supplied-pmid 10757739?><pub-id pub-id-type="pmid">10757739</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marston</surname><given-names>A</given-names></name><name><surname>Zagorski</surname><given-names>MG</given-names></name><name><surname>Hostettmann</surname><given-names>K</given-names></name></person-group><article-title>Antifungal polyphenols from <italic>Cordia goetzei</italic></article-title><source>Helv Chim Acta</source><year>1988</year><volume>71</volume><fpage>1210</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1002/hlca.19880710532</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>T</given-names></name><name><surname>Canales</surname><given-names>M</given-names></name><name><surname>Teran</surname><given-names>B</given-names></name><name><surname>Avila</surname><given-names>O</given-names></name><name><surname>Duran</surname><given-names>A</given-names></name><name><surname>Garcia</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Antimicrobial activity of the essential oil and extracts of <italic>Cordia curassavica</italic> (Boraginaceae)</article-title><source>J Ethnopharmacol</source><year>2007</year><volume>111</volume><fpage>137</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.11.002</pub-id><?supplied-pmid 17140754?><pub-id pub-id-type="pmid">17140754</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okusa</surname><given-names>PN</given-names></name><name><surname>Penge</surname><given-names>O</given-names></name><name><surname>Devleeschouwer</surname><given-names>M</given-names></name><name><surname>Duez</surname><given-names>P</given-names></name></person-group><article-title>Direct and indirect antimicrobial effects and antioxidant activity of <italic>Cordia gilletii</italic> De Wild (Boraginaceae)</article-title><source>J Ethnopharmacol</source><year>2007</year><volume>112</volume><fpage>476</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.04.003</pub-id><?supplied-pmid 17537602?><pub-id pub-id-type="pmid">17537602</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamkhande</surname><given-names>PG</given-names></name><name><surname>Ghante</surname><given-names>MH</given-names></name><name><surname>Barde</surname><given-names>SR</given-names></name><name><surname>Ajgunde</surname><given-names>BR</given-names></name></person-group><article-title>Antimycobacterial, antimicrobial, antioxidant activities and <italic>in silico</italic> PASS investigations of root fractions and extract of <italic>Cordia dichotoma</italic></article-title><source>Orient Pharm Exp Med</source><year>2019</year><volume>19</volume><fpage>485</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1007/s13596-019-00399-5</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>MV</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Paech</surname><given-names>K</given-names></name><name><surname>Tracey</surname><given-names>MV</given-names></name></person-group><article-title>Urea and ureides</article-title><source>Modern methods of plant analysis</source><year>1955</year><publisher-loc>Berlin</publisher-loc><publisher-name>Springer</publisher-name><fpage>119</fpage><lpage>141</lpage></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>VC</given-names></name><name><surname>de Carvalho</surname><given-names>MG</given-names></name><name><surname>Alves</surname><given-names>AN</given-names></name></person-group><article-title>Chemical constituents from leaves of <italic>Palicourea coriacea</italic> (Rubiaceae)</article-title><source>J Nat Med</source><year>2008</year><volume>62</volume><fpage>356</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1007/s11418-008-0227-2</pub-id><?supplied-pmid 18404310?><pub-id pub-id-type="pmid">18404310</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kus</surname><given-names>N</given-names></name><name><surname>Bayar</surname><given-names>SH</given-names></name><name><surname>Fausto</surname><given-names>R</given-names></name></person-group><article-title>Thermal decomposition of allantoin as probed by matrix isolation FTIR spectroscopy</article-title><source>Tetrahedron</source><year>2009</year><volume>65</volume><fpage>9719</fpage><lpage>9727</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2009.09.088</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>MJ</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name></person-group><article-title>FTIR, FT-Raman, UV&#x02013;visible spectra and quantum chemical calculations of allantoin molecule and its hydrogen bonded dimers</article-title><source>Spectrochim Acta A</source><year>2015</year><volume>136</volume><fpage>961</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1016/j.saa.2014.09.119</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nariya</surname><given-names>PB</given-names></name><name><surname>Shukla</surname><given-names>VJ</given-names></name><name><surname>Acharya</surname><given-names>RN</given-names></name><name><surname>Nariya</surname><given-names>MB</given-names></name><name><surname>Dhalani</surname><given-names>JM</given-names></name><name><surname>Patel</surname><given-names>AS</given-names></name><name><surname>Ambasana</surname><given-names>PA</given-names></name></person-group><article-title>Triterpenoid and fatty acid contents from the stem bark of <italic>Cordia dichotoma</italic></article-title><source>Folia Med (Plovdiv)</source><year>2018</year><volume>60</volume><fpage>594</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.2478/folmed-2018-0026</pub-id><pub-id pub-id-type="pmid">31188773</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinney</surname><given-names>JD</given-names></name><name><surname>H&#x000f6;ner zu Bentrup</surname><given-names>K</given-names></name><name><surname>Mu&#x000f1;oz-El&#x000ed;as</surname><given-names>EJ</given-names></name><name><surname>Miczak</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Chan</surname><given-names>WT</given-names></name><name><surname>Swenson</surname><given-names>D</given-names></name><name><surname>Sacchettini</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Persistence of <italic>Mycobacterium tuberculosis</italic> in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase</article-title><source>Nature</source><year>2000</year><volume>406</volume><fpage>735</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1038/35021074</pub-id><?supplied-pmid 10963599?><pub-id pub-id-type="pmid">10963599</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname><given-names>M</given-names></name><name><surname>Yamano</surname><given-names>Y</given-names></name><name><surname>Kamiya</surname><given-names>K</given-names></name><name><surname>Setiawan</surname><given-names>A</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name></person-group><article-title>Anti-dormant mycobacterial activity and target molecule of melophlins, tetramic acid derivatives isolated from a marine sponge of <italic>Melophlus</italic> sp</article-title><source>J Nat Med</source><year>2016</year><volume>70</volume><fpage>467</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1007/s11418-016-1005-1</pub-id><?supplied-pmid 27193014?><pub-id pub-id-type="pmid">27193014</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawal</surname><given-names>TO</given-names></name><name><surname>Mbanu</surname><given-names>AE</given-names></name><name><surname>Adeniyi</surname><given-names>BA</given-names></name></person-group><article-title>Inhibitory activities of <italic>Ceiba</italic><italic>pentandra</italic> (L.) Gaertn and <italic>Cordia</italic><italic>sebestena</italic> Linn. on selected rapidly growing mycobacteria</article-title><source>Afr J Microbiol Res</source><year>2014</year><volume>28</volume><fpage>2387</fpage><lpage>2392</lpage></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Sorribas</surname><given-names>A</given-names></name><name><surname>Yoshida</surname><given-names>WY</given-names></name><name><surname>Williams</surname><given-names>PG</given-names></name></person-group><article-title>Sebestenoids A-D, BACE1 inhibitors from <italic>Cordia sebestena</italic></article-title><source>Phytochemistry</source><year>2010</year><volume>71</volume><fpage>2168</fpage><lpage>2173</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2010.09.008</pub-id><?supplied-pmid 20952040?><pub-id pub-id-type="pmid">20952040</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rekha</surname><given-names>M</given-names></name><name><surname>Kowsalya</surname><given-names>M</given-names></name></person-group><article-title>A new organic dye <italic>Cordia sebestena</italic> sensitized solar cell with current-voltage characteristics</article-title><source>Asian J Chem</source><year>2020</year><volume>32</volume><fpage>342</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.14233/ajchem.2020.22405</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aayisha</surname><given-names>S</given-names></name><name><surname>Devi</surname><given-names>TSR</given-names></name><name><surname>Janani</surname><given-names>S</given-names></name><name><surname>Muthu</surname><given-names>S</given-names></name><name><surname>Raja</surname><given-names>M</given-names></name><name><surname>Sevvanthi</surname><given-names>S</given-names></name></person-group><article-title>DFT, molecular docking and experimental FT-IR, FT-Raman, NMR inquisitions on &#x0201c;4-chloro-<italic>N</italic>-(4,5-dihydro-1<italic>H</italic>-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine&#x0201d;: alpha-2-imidazoline receptor agonist antihypertensive agent</article-title><source>J Mol Struct</source><year>2019</year><volume>1186</volume><fpage>468</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1016/j.molstruc.2019.03.056</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>CX</given-names></name><name><surname>Jian-Xia Mo</surname><given-names>JX</given-names></name><name><surname>Wang</surname><given-names>XY</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Gan</surname><given-names>LS</given-names></name></person-group><article-title>Theoretical study on flueggenines A and B: a comparison of calculated spectroscopic properties with IR, UV and ECD experimental data</article-title><source>J Mol Struct</source><year>2011</year><volume>989</volume><fpage>131</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.molstruc.2010.12.051</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becke</surname><given-names>DA</given-names></name></person-group><article-title>Density-functional thermochemistry. III. The role of exact exchange</article-title><source>J Chem Phys</source><year>1993</year><volume>98</volume><fpage>5648</fpage><lpage>5652</lpage><pub-id pub-id-type="doi">10.1063/1.464913</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Parr</surname><given-names>RG</given-names></name></person-group><article-title>Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density</article-title><source>Phys Rev B</source><year>1988</year><volume>37</volume><fpage>785</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1103/PhysRevB.37.785</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamo</surname><given-names>C</given-names></name><name><surname>Barone</surname><given-names>V</given-names></name></person-group><article-title>Exchange functionals with improved long-range behavior and adiabatic connection methods without adjustable parameters: the <italic>m</italic>PW and <italic>m</italic>PW1PW models</article-title><source>J Chem Phys</source><year>1998</year><volume>108</volume><fpage>664</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1063/1.475428</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perdew</surname><given-names>JP</given-names></name><name><surname>Chevary</surname><given-names>JA</given-names></name><name><surname>Vosko</surname><given-names>SH</given-names></name><name><surname>Jackson</surname><given-names>KA</given-names></name><name><surname>Pederson</surname><given-names>MR</given-names></name><name><surname>Singh</surname><given-names>DJ</given-names></name><name><surname>Fiolhais</surname><given-names>C</given-names></name></person-group><article-title>Atoms, molecules, solids, and surfaces: applications of the generalized gradient approximation for exchange and correlation</article-title><source>Phys Rev B</source><year>1992</year><volume>46</volume><fpage>6671</fpage><lpage>6687</lpage><pub-id pub-id-type="doi">10.1103/PhysRevB.46.6671</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeukang</surname><given-names>RD</given-names></name><name><surname>Noundou</surname><given-names>XS</given-names></name><name><surname>Fotsing</surname><given-names>MT</given-names></name><name><surname>Kuiate</surname><given-names>TT</given-names></name><name><surname>Mbafor</surname><given-names>JT</given-names></name><name><surname>Krause</surname><given-names>RWM</given-names></name><etal/></person-group><article-title>Cordidepsine is a potential new anti-HIV depsidone from <italic>Cordia millenii</italic></article-title><source>Molecules</source><year>2019</year><volume>24</volume><fpage>3202</fpage><lpage>3216</lpage><pub-id pub-id-type="doi">10.3390/molecules24173202</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Feng</surname><given-names>ZX</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Huan</surname><given-names>W</given-names></name><name><surname>Gang</surname><given-names>WD</given-names></name><name><surname>Dong</surname><given-names>LX</given-names></name></person-group><article-title>Chemical constituents from the whole plant of <italic>Euphorbia altotibetic</italic></article-title><source>Helv Chim Acta</source><year>2003</year><volume>86</volume><fpage>2525</fpage><lpage>2532</lpage><pub-id pub-id-type="doi">10.1002/hlca.200390204</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velde</surname><given-names>VV</given-names></name><name><surname>Lavie</surname><given-names>D</given-names></name><name><surname>Zelnik</surname><given-names>R</given-names></name><name><surname>Matida</surname><given-names>AK</given-names></name><name><surname>Panizza</surname><given-names>S</given-names></name></person-group><article-title>Cordialin A and B, two new triterpenes from <italic>Cordia verbenacea</italic></article-title><source>J Chem Soc Perkin Trans</source><year>1982</year><volume>1</volume><fpage>2697</fpage><lpage>2700</lpage><pub-id pub-id-type="doi">10.1039/p19820002697</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Formica</surname><given-names>JV</given-names></name><name><surname>Regelson</surname><given-names>W</given-names></name></person-group><article-title>Review of the biology of quercetin and related bioflavonoids</article-title><source>Food Chem Toxicol</source><year>1995</year><volume>33</volume><fpage>1061</fpage><lpage>1080</lpage><pub-id pub-id-type="doi">10.1016/0278-6915(95)00077-1</pub-id><?supplied-pmid 8847003?><pub-id pub-id-type="pmid">8847003</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hergert</surname><given-names>HL</given-names></name></person-group><article-title>The flavonoids of lodgepole pine bark</article-title><source>J Org Chem</source><year>1956</year><volume>21</volume><fpage>534</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1021/jo01111a013</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coughlin</surname><given-names>JL</given-names></name><name><surname>Winnik</surname><given-names>B</given-names></name><name><surname>Buckley</surname><given-names>B</given-names></name></person-group><article-title>Measurement of bisphenol A, bisphenol A &#x003b2;-D-glucuronide, genistein, and genistein 4&#x02032;-&#x003b2;-D-glucuronide via SPE and HPLC&#x02013;MS/MS</article-title><source>Anal Bioanal Chem</source><year>2011</year><volume>401</volume><fpage>995</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1007/s00216-011-5151-8</pub-id><?supplied-pmid 21667348?><pub-id pub-id-type="pmid">21667348</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deliy</surname><given-names>IV</given-names></name><name><surname>Vlasova</surname><given-names>EN</given-names></name><name><surname>Nuzhdin</surname><given-names>AL</given-names></name><name><surname>Gerasimov</surname><given-names>EY</given-names></name><name><surname>Bukhtiyarova</surname><given-names>GA</given-names></name></person-group><article-title>Hydrodeoxygenation of methyl palmitate over sulfided Mo/Al<sub>2</sub>O<sub>3</sub>, CoMo/Al<sub>2</sub>O<sub>3</sub> and NiMo/Al<sub>2</sub>O<sub>3</sub> catalysts</article-title><source>RSC Adv</source><year>2014</year><volume>4</volume><fpage>2242</fpage><lpage>2250</lpage><pub-id pub-id-type="doi">10.1039/C3RA46164E</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Hong</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>HW</given-names></name><name><surname>Wang</surname><given-names>NL</given-names></name><name><surname>Zhuang</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>XS</given-names></name></person-group><article-title>New steryl esters of fatty acids from the mangrove fungus <italic>Aspergillus awamori</italic></article-title><source>Helv Chim Acta</source><year>2007</year><volume>90</volume><fpage>1165</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1002/hlca.200790116</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Shouny</surname><given-names>WA</given-names></name><name><surname>Ali</surname><given-names>SS</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Samy</surname><given-names>SL</given-names></name><name><surname>Ali</surname><given-names>A</given-names></name></person-group><article-title>Drug resistance profile and molecular characterization of extended spectrum beta-lactamase (ES&#x003b2;L)-producing <italic>Pseudomonas aeruginosa</italic> isolated from burn wound infections; essential oils and their potential for utilization</article-title><source>Microb Pathog</source><year>2018</year><volume>116</volume><fpage>301</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.02.005</pub-id><?supplied-pmid 29407236?><pub-id pub-id-type="pmid">29407236</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazi</surname><given-names>SA</given-names></name><name><surname>Clark</surname><given-names>P</given-names></name><name><surname>Campi</surname><given-names>EM</given-names></name><name><surname>Jackson</surname><given-names>WR</given-names></name><name><surname>Hearn</surname><given-names>MTW</given-names></name></person-group><article-title>Metathesis reactions with a low-cost spinning disk system</article-title><source>Green Chem Lett Rev</source><year>2019</year><volume>12</volume><fpage>407</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1080/17518253.2019.1679264</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azuma</surname><given-names>CM</given-names></name><name><surname>dos Santos</surname><given-names>FCS</given-names></name><name><surname>Lago</surname><given-names>JHG</given-names></name></person-group><article-title>Flavonoids and fatty acids of <italic>Camellia japonica</italic> leaves extract</article-title><source>Braz Pharmacogn</source><year>2011</year><volume>21</volume><fpage>1159</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.1590/S0102-695X2011005000128</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="other">Nie Y &#x00026; St&#x000fc;rzenbaum SR. Model nematodes. In: Obesity research in animal models for the study of human disease. 2nd edn. Amsterdam: Elsevier Inc; 2017. p. 267&#x02013;80.</mixed-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakshmanan</surname><given-names>G</given-names></name><name><surname>Sivaraj</surname><given-names>C</given-names></name><name><surname>Ammar</surname><given-names>A</given-names></name><name><surname>Krishnan</surname><given-names>DA</given-names></name><name><surname>Gopinath</surname><given-names>S</given-names></name><name><surname>Saravanan</surname><given-names>K</given-names></name><etal/></person-group><article-title>Isolation and structural elucidation of allantoin, a bioactive compound from <italic>Cleome viscosa</italic>: a combined experimental and computational investigation</article-title><source>Pharmacogn J</source><year>2019</year><volume>11</volume><fpage>1391</fpage><lpage>1400</lpage><pub-id pub-id-type="doi">10.5530/pj.2019.11.215</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulmer</surname><given-names>GR</given-names></name><name><surname>Miller</surname><given-names>AJM</given-names></name><name><surname>Sherden</surname><given-names>NH</given-names></name><name><surname>Gottlieb</surname><given-names>HE</given-names></name><name><surname>Nudelman</surname><given-names>A</given-names></name><name><surname>Stoltz</surname><given-names>BM</given-names></name><etal/></person-group><article-title>NMR chemical shifts of trace impurities: common laboratory solvents, organics, and gases in deuterated solvents relevant to the organometallic chemist</article-title><source>Organometallics</source><year>2010</year><volume>29</volume><fpage>2176</fpage><lpage>2179</lpage><pub-id pub-id-type="doi">10.1021/om100106e</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smilkstein</surname><given-names>M</given-names></name><name><surname>Sriwilaijaroen</surname><given-names>N</given-names></name><name><surname>Kelly</surname><given-names>JX</given-names></name><name><surname>Wilairat</surname><given-names>D</given-names></name><name><surname>Riscoe</surname><given-names>M</given-names></name></person-group><article-title>Simple and inexpensive fluorescence based technique for high-throughput antimalarial screening</article-title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><fpage>1803</fpage><lpage>1806</lpage><pub-id pub-id-type="doi">10.1128/AAC.48.5.1803-1806.2004</pub-id><?supplied-pmid 15105138?><pub-id pub-id-type="pmid">15105138</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantrell</surname><given-names>CL</given-names></name><name><surname>Franzblau</surname><given-names>SG</given-names></name><name><surname>Fischer</surname><given-names>NH</given-names></name></person-group><article-title>Antimycobacterial plant terpenoids</article-title><source>Planta Med</source><year>2001</year><volume>67</volume><fpage>685</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1055/s-2001-18365</pub-id><?supplied-pmid 11731906?><pub-id pub-id-type="pmid">11731906</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>JQ</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Franzblau</surname><given-names>SG</given-names></name><name><surname>Montenegro</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Timmermann</surname><given-names>BN</given-names></name></person-group><article-title>Antitubercular constituents of <italic>Valeriana laxiflora</italic></article-title><source>Planta Med</source><year>2004</year><volume>70</volume><fpage>509</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1055/s-2004-827149</pub-id><?supplied-pmid 15229801?><pub-id pub-id-type="pmid">15229801</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mootz</surname><given-names>D</given-names></name></person-group><article-title>The crystal structure of DL-allantoin</article-title><source>Acta Cryst</source><year>1965</year><volume>19</volume><fpage>726</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1107/S0365110X65004280</pub-id><pub-id pub-id-type="pmid">5897688</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asia</surname><given-names>NR</given-names></name><name><surname>Fatma</surname><given-names>UA</given-names></name><name><surname>Mayades</surname><given-names>S</given-names></name><name><surname>Mutasem</surname><given-names>OT</given-names></name></person-group><article-title>Investigation of the active constituents of <italic>Portulaca oleraceae</italic> (Portulacaceae) growing in Jordan</article-title><source>Pak J Pharm Sci</source><year>2004</year><volume>17</volume><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">16414585</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauli</surname><given-names>GF</given-names></name><name><surname>Case</surname><given-names>RJ</given-names></name><name><surname>Inui</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Fischer</surname><given-names>NH</given-names></name><name><surname>Franzblau</surname><given-names>SG</given-names></name></person-group><article-title>New perspectives on natural products in TB drug research</article-title><source>Life Sci</source><year>2005</year><volume>78</volume><fpage>485</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2005.09.004</pub-id><?supplied-pmid 16243360?><pub-id pub-id-type="pmid">16243360</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>LR</given-names></name><name><surname>Shanholtzer</surname><given-names>CJ</given-names></name></person-group><article-title>Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance</article-title><source>Clin Microbiol Rev</source><year>1992</year><volume>5</volume><fpage>420</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1128/CMR.5.4.420</pub-id><?supplied-pmid 1423219?><pub-id pub-id-type="pmid">1423219</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiam</surname><given-names>ER</given-names></name><name><surname>Bikobo</surname><given-names>SDN</given-names></name><name><surname>Zintchem</surname><given-names>AAA</given-names></name><name><surname>Nyemeck</surname><given-names>NM</given-names><suffix>II</suffix></name><name><surname>Ndedi</surname><given-names>EDFM</given-names></name><name><surname>Dibou&#x000e9;</surname><given-names>PHB</given-names></name><etal/></person-group><article-title>Secondary metabolites from <italic>Triclisia gilletii</italic>(Menispermaceae) withantimycobacterial activity against <italic>Mycobacterium tuberculosis</italic></article-title><source>Nat Prod Res</source><year>2019</year><volume>33</volume><fpage>642</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1080/14786419.2017.1402324</pub-id><?supplied-pmid 29144174?><pub-id pub-id-type="pmid">29144174</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trager</surname><given-names>W</given-names></name><name><surname>Jensen</surname><given-names>JB</given-names></name></person-group><article-title>Human malaria parasites in continuous culture</article-title><source>Science</source><year>1976</year><volume>193</volume><fpage>673</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1126/science.781840</pub-id><?supplied-pmid 781840?><pub-id pub-id-type="pmid">781840</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>L</given-names></name><name><surname>Franzblau</surname><given-names>SG</given-names></name></person-group><article-title>Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against <italic>Mycobacterium tuberculosis</italic> and <italic>Mycobacterium avium</italic></article-title><source>Antimicrob Agents Chemother</source><year>1997</year><volume>41</volume><fpage>1004</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1128/AAC.41.5.1004</pub-id><?supplied-pmid 9145860?><pub-id pub-id-type="pmid">9145860</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>CLSI</collab></person-group><source>Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes&#x02013;second edition, Approved Standard M24&#x02013;A2</source><year>2011</year><publisher-loc>Wayne</publisher-loc><publisher-name>Clinical and Laboratory Standards Institute</publisher-name></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Frisch</surname><given-names>MJ</given-names></name><name><surname>Trucks</surname><given-names>GW</given-names></name><name><surname>Schlegel</surname><given-names>HB</given-names></name><name><surname>Scuseria</surname><given-names>GE</given-names></name><name><surname>Robb</surname><given-names>MA</given-names></name><name><surname>Cheeseman</surname><given-names>JR</given-names></name><etal/></person-group><source>Gaussian 09, Revision B.01</source><year>2010</year><publisher-loc>Wallingford</publisher-loc><publisher-name>Gaussian Inc.</publisher-name></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Boyle</surname><given-names>NM</given-names></name><name><surname>Tenderholt</surname><given-names>AL</given-names></name><name><surname>Langner</surname><given-names>KM</given-names></name></person-group><source>J Comp Chem</source><year>2008</year><volume>29</volume><fpage>839</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1002/jcc.20823</pub-id><pub-id pub-id-type="pmid">17849392</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzaei</surname><given-names>M</given-names></name><name><surname>Elmi</surname><given-names>F</given-names></name><name><surname>Hadipour</surname><given-names>NL</given-names></name></person-group><article-title>A systematic investigation of hydrogen-bonding effects on the <sup>17</sup>O, <sup>14</sup>N, and <sup>2</sup>H nuclear quadrupole resonance parameters of anhydrous and monohydrated cytosine crystalline structures: a density functional theory study</article-title><source>J Phys Chem B</source><year>2006</year><volume>110</volume><fpage>10991</fpage><lpage>10996</lpage><pub-id pub-id-type="doi">10.1021/jp060301g</pub-id><?supplied-pmid 16771352?><pub-id pub-id-type="pmid">16771352</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behzadi</surname><given-names>H</given-names></name><name><surname>Hadipour</surname><given-names>NL</given-names></name><name><surname>Mirzaei</surname><given-names>M</given-names></name></person-group><article-title>A density functional study of <sup>17</sup>O, <sup>14</sup>N and <sup>2</sup>H electric field gradient tensors in the real crystalline structure of &#x003b1;-glycine</article-title><source>Biophys Chem</source><year>2007</year><volume>125</volume><fpage>179</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.bpc.2006.07.010</pub-id><?supplied-pmid 16914262?><pub-id pub-id-type="pmid">16914262</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coxon</surname><given-names>B</given-names></name><name><surname>Fatiadi</surname><given-names>AJ</given-names></name><name><surname>Sniegoski</surname><given-names>LT</given-names></name><name><surname>Hertz</surname><given-names>HS</given-names></name><name><surname>Schaffer</surname><given-names>R</given-names></name></person-group><article-title>A novel acylative degradation of uric acid, Carbon-13 nuclear magnetic resonance studies of uric acid and its degradation products</article-title><source>J Org Chem</source><year>1977</year><volume>42</volume><fpage>3132</fpage><lpage>3140</lpage><pub-id pub-id-type="doi">10.1021/jo00439a006</pub-id><?supplied-pmid 894395?><pub-id pub-id-type="pmid">894395</pub-id></element-citation></ref></ref-list></back></article>